Efficacy and safety of GMRx2 (a single pill combination containing telmisartan/amlodipine/indapamide) compared to dual combinations for the treatment of hypertension: An international, multi-center, randomized, double-blind, active-controlled, parallel-group trial. - Trial SLCTR_2021_007
Access comprehensive clinical trial information for SLCTR_2021_007 through Pure Global AI's free database. This Phase 3 trial is sponsored by Dr. Karl Roberts and is currently Recruiting. The study focuses on Hypertension.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2021_007
Phase 3
Recruiting
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2021_007
Efficacy and safety of GMRx2 (a single pill combination containing telmisartan/amlodipine/indapamide) compared to dual combinations for the treatment of hypertension: An international, multi-center, randomized, double-blind, active-controlled, parallel-group trial.
Study Focus
Interventional
Sponsor & Location
Dr. Karl Roberts
Sri Lanka
Timeline & Enrollment
Phase 3
Sep 03, 2021
N/A
ICD-10 Classifications
Hypertensive diseases
Renovascular hypertension
Secondary hypertension
Other secondary hypertension
Hypertensive heart disease
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2021_007
Non-Device Trial